The Discounted Cash Flow (DCF) valuation of Cytokinetics Inc (CYTK) is (150.37) USD. With the latest stock price at 57.78 USD, the upside of Cytokinetics Inc based on DCF is -360.2%.
Based on the latest price of 57.78 USD and our DCF valuation, Cytokinetics Inc (CYTK) is a sell. selling CYTK stocks now will result in a potential gain of 360.2%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 9.8% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (439.75) - (94.43) | (150.37) |
| Upside | -861.1% - -263.4% | -360.2% |